Spots Global Cancer Trial Database for drug evaluation
Every month we try and update this database with for drug evaluation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | NCT00000660 | Sarcoma, Kaposi HIV Infections | Etoposide | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma | NCT00001113 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine Interferon alfa... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | NCT00000681 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine Sargramostim | 14 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma | NCT00000687 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | NCT00000681 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine Sargramostim | 14 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS | NCT00000646 | HIV Infections | Pentoxifylline | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma | NCT00000694 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine Sargramostim | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma | NCT00001113 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine Interferon alfa... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer | NCT00000723 | Lymphoma, Non-H... HIV Infections | Methotrexate Leucovorin calc... Zidovudine Dexamethasone | 18 Years - 70 Years | National Institute of Allergy and Infectious Diseases (NIAID) |